Mobile Menu - OpenMobile Menu - Closed

Connect

Twitter icon
Facebook icon
Flickr icon
YouTube icon
RSS icon

Congresswoman Elise Stefanik

Representing the 21st District of New York

Stefanik Leads Bipartisan Freshmen Letter to the Speaker on Medical Device Tax Repeal

March 31, 2015
Press Release

Washington, D.C. – Today, Congresswoman Elise Stefanik (R-NY-21), Freshman Representative to the Policy Committee, led a bipartisan group of freshmen lawmakers in sending a letter to Speaker John Boehner (R-OH-08) urging him to bring H.R. 160, the Protect Medical Innovation Act, up for a vote in the House. The lawmakers wrote:

We write to urge you to consider fast-tracking consideration of H.R. 160, the Protect Medical Innovation Act, authored by our colleague Erik Paulsen. It is critical that the House acts to protect the medical device industry prior to any action by the United States Supreme Court this spring. This legislation enjoys broad bipartisan support as members of both parties recognize the impact this has on our constituents, both in access to the healthcare devices they need, and in hundreds of thousands employed by the industry.

The medical device industry directly employs 400,000 Americans. The industry is primarily comprised of small businesses and American companies represent 38% of the global market. Of the 6,500 medical device manufacturers in the United States, 80% employ fewer than 50 employees.

The 2.3% tax on revenue, rather than income, means that the U.S. device industry is subject to one of the highest corporate tax rates in the world. And many smaller early-stage companies must pay the tax even though they are years away from becoming profitable. As companies look to make cuts to offset the tax, one of the first items to go is research and development. This undermines the future of the industry, and puts the discovery of new breakthrough medical technologies at risk.

Additionally, the tax revenue generated from medical devices is approximately $2 billion annually. Relative to the federal budget, this represents roughly one half of one tenth of one percent of government spending. Repealing the tax will not have a meaningful impact on the budget, but will be significant for these small businesses and their ability to continue to grow.

As freshmen members, we made a promise to our constituents to usher in a new era of cooperation in order to restore faith in our government institutions. Repealing the medical device tax is too important to our constituents and small businesses not to act immediately, and proves that we can come together with solutions. We ask that you consider fast-tracking consideration of H.R. 160 during the three-week Congressional work period in April and work with us to include repeal in any legislative packages that develop this year in order to give our nation’s small businesses the certainty they need.

For a digital copy of the letter, click here.

Joining Congresswoman Stefanik on the letter were Reps. Ralph Abraham (LA-05), Pete Aguilar (CA-31), Brad Ashford (NE-02), Brian Babin (TX-36), Mike Bishop (MI-08), Rod Blum (IA-01), Mike Bost (IL-12), Dave Brat (VA-07), Ken Buck (CO-04), E.L “Buddy” Carter (GA-01), Barbara Comstock (VA-10), Ryan Costello (PA-06), Carlos Curbelo (FL-26), Robert Dold (IL-10), Tom Emmer (MN-06), Gwen Graham (FL-02), Frank Guinta (NH-01), Crescent Hardy (NV-04), Jody Hice (GA-10), French Hill (AR-02), Will Hurd (TX-23), Evan Jenkins (WV-03), John Katko (NY-24), Steve Knight (CA-25), Mia Love (UT-04), Barry Loudermilk (GA-11), Tom MacArthur (NJ-03), Martha McSally (AZ-02), John Moolenaar (MI-04), Seth Moulton (MA-06), Dan Newhouse (WA-04), Gary Palmer (AL-06), Bruce Poliquin (ME-02), John Ratcliffe (TX-04), David Rouzer (NC-07), Steve Russell (OK-05), Dave Trott (MI-11), Mark Walker (NC-06), Mimi Walters (CA-45), Bruce Westerman (AR-04), David Young (IA-03), Ryan Zinke (MT).

###